Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Effect of Remifentanil on the Objectively Measured Pressure Pain Threshold

NCT: NCT07568405 · ENROLLING_BY_INVITATION

NCT IDNCT07568405
StatusENROLLING_BY_INVITATION
Start Date2026-01-26
Completion2026-06-15

Brief Summary

It is a clinical study investigating the relationship between objectively measured pain threshold and the need for escalating doses of remifentanyl opioids. This study is expected to include approximately 40 participants. The aim of the study is to objectively measure the analgesic effect of an increasing dose of opioids just before anesthesia.

Frequently Asked Questions

What is The Effect of Remifentanil on the Objectively Measured Pressure Pain Threshold?

The Effect of Remifentanil on the Objectively Measured Pressure Pain Threshold is a clinical trial registered under NCT07568405. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07568405?

The current status of NCT07568405 (The Effect of Remifentanil on the Objectively Measured Pressure Pain Threshold) is: ENROLLING_BY_INVITATION.

When did The Effect of Remifentanil on the Objectively Measured Pressure Pain Threshold start?

The Effect of Remifentanil on the Objectively Measured Pressure Pain Threshold started on 2026-01-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑